Anti-tumour necrosis factor-alpha antibody

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAnti-tumour necrosis factor-alpha antibody
Drug Alias NameAnti-TNF-alpha antibody oral抗肿瘤坏死因子α抗体Anti-tumour necrosis factor-α antibodyAnti-tumour necrosis factor-alfa antibodyArtrofoon +[6] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsOsteoarthritisArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMateria Medica Holding Research And Production Company
China Registration ClassN/A

Develop Information

Active CompaniesMateria Medica Holding Research And Production Company
Inactive CompaniesN/A
Active IndicationsOsteoarthritisArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeL01XC
Related LinksN/A